ReviewFrontiers in cardiovascular medicine2026
BMI, race and AF recurrence post ablation: a meta-analysis and systematic review.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Obesity increases atrial fibrillation (AF) risk, but it remains unclear whether this association can be extrapolated to AF patients who undergoing pulmonary vein isolation (PVI), and whether there are racial differences. This study aims to explore the role and interaction of body mass index (BMI) and racial factors in the risk of AF recurrence post PVI. Methods: A systematic search was conducted in PubMed, Web of Science, Engineering Index, Wan Fang database, CNKI, and relevant meta-analyses from database inception to May 19, 2025. Standardized data extraction was performed in accordance with the Meta-analysis of Observational Studies in Epidemiology Reporting Guidelines. Primary outcome was the recurrence of AF post PVI. Secondary outcomes included procedural complications, and echocardiographic parameters. Results: Finally, 26 studies involving 35,237 individuals were included. The results showed a linear positive correlation between BMI and the risk of AF recurrence post PVI. For every 5-units increase in BMI, the recurrence risk of AF increased by 9%. Subgroup analysis indicated that obese Europeans had a 9% higher recurrence risk ( Conclusion: Our findings confirm a linear positive correlation between BMI and the risk of AF recurrence post PVI. An enlarged left atrial diameter may be one potential mechanisms underlying AF recurrence. Furthermore, significant racial disparities were identified in AF recurrence risk, with Asian patients showing a significantly higher recurrence risk than European and American patients. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024496463, PROSPERO CRD42024496463.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.